Evidence map›Paper›PMID 28783972›Full record

ArticleClinical trials (London, England)2017

Motivations, enrollment decisions, and socio-demographic characteristics of healthy volunteers in phase 1 research.

Christine Grady, Gabriella Bedarida, Ninet Sinaii, Mark Anthony Gregorio, Ezekiel J Emanuel

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Clinical trials (London, England), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Why do healthy volunteers participate in clinical trials?British journal of clinical pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
  14. Article
  15. Volunteering for Infection: Participant Perspectives on a Hepatitis C Virus Controlled Human Infection Model.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  16. "Death and Taxes": Why Financial Compensation for Research Participants is an Economic and Legal Risk.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2023
    Article
  17. Article
  18. Article
  19. The ethical anatomy of payment for research participants.Medicine, health care, and philosophy · 2022
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Christine Grady1 The Department of Bioethics, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Gabriella Bedarida2 New Haven Clinical Research Unit, Pfizer Inc., New Haven, CT, USA.
Ninet Sinaii3 Biostatistics and Clinical Epidemiology Service, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Mark Anthony Gregorio2 New Haven Clinical Research Unit, Pfizer Inc., New Haven, CT, USA.
Ezekiel J Emanuel4 The Department of Medical Ethics & Health Policy, University of Pennsylvania, Philadelphia, PA, USA.
National Institutes of Health Clinical Center · USPfizer (United States) · USUniversity of Pennsylvania · US

Funding

Motivations for participation in phase 1 drug development trialsZIACL010534 · CLC · CLINICAL CENTER · PI GRADY, CHRISTINE P · 2010 to 2018
$0k
Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

BACKGROUND/

aimPhase 1 trials with healthy volunteers are an integral step in drug development. Commentators worry about the possible exploitation of healthy volunteers because they are assumed to be disadvantaged, marginalized, and inappropriately influenced by the offer of money for research for which they do not appreciate the inherent risks. Yet there are limited data to support or refute these concerns. This study aims to describe the socio-demographic characteristics, motivations, and enrollment decision-making of a large cohort of healthy volunteers.

methodsWe used a cross-sectional anonymous survey of 1194 healthy volunteers considering enrollment in phase 1 studies at Pfizer Clinical Research Units in New Haven, CT; Brussels, Belgium; and Singapore. Descriptive statistics describe motivations and socio-demographic characteristics. Comparisons between groups were examined.

resultsThe majority rated consideration of risks as more important to their enrollment decision than the amount of money, despite reporting that their primary motivation was financial. Risk, time, money, the competence and friendliness of research staff, and contributing to medical research were important factors influencing enrollment decisions for most participants. The majority of healthy volunteers in this cohort were male, single, reported higher than high school education, and 70% had previous research experience. Many reported low annual incomes (50% below USD$25,000) and high rates of unemployment (33% overall). Nonetheless, risk as an important consideration, money, and other reported considerations and motivations, except for time, did not vary by income, employment, education, or previous experience. There were regional differences in both socio-demographic characteristics and factors important to participation decisions.

conclusionHealthy volunteers in phase 1 studies consider risks as more important to their enrollment decisions than the amount of money offered, although most are motivated to participate by the offer of money. Healthy volunteers are indeed low income, disproportionately unemployed, and have significant prior research experience. Yet these factors do not appear to affect either their motivations for participation or factors important to their research enrollment decisions.

Indexed as

Decision MakingSocioeconomic FactorsAdultClinical Trials, Phase I as TopicCross-Sectional StudiesFemaleHealthy VolunteersHumansMaleMiddle AgedMotivationPatient SelectionRisk AssessmentSurveys and QuestionnairesYoung Adultfinancial incentivesHealthy volunteersmotivations

Identifiers

PMID28783972
PMCPMC9896431
OpenAlexW2749716614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.